Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 180,236 shares at $9.36 ($1.7M) on 2023-12-11, disclosed to the SEC on 2023-12-13.
Open-market purchase of $1.7M PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.36 | 90,118 | $844K | 50.0% |
| 2 | $9.36 | 90,118 | $844K | 50.0% |
| Total | $9.36 avg | 180,236 | $1.7M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |